{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:16Z","timestamp":1787504056570,"version":"build-2736575974"},"reference-count":65,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14330","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T07:45:41Z","timestamp":1709797541000},"source":"Crossref","is-referenced-by-count":15,"title":["Effect of valproic acid on histone deacetylase expression in oral cancer (Review)"],"prefix":"10.3892","volume":"27","author":[{"given":"Ahmed","family":"Al\u2011Khafaji","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L7 8TX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Wang","sequence":"additional","affiliation":[{"name":"Centre for Haemato\u2011Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar","family":"Alabdei","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Warith Al\u2011Anbiyaa, Karbala 56001, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafillos","family":"Liloglou","sequence":"additional","affiliation":[{"name":"Cardiorespiratory Research Centre, Medical School, Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, Lancashire L39 4QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"key20240412091849_b1-ol-27-5-14330","article-title":"Head and neck cancers statistics","author":"Cancer Research UK"},{"key":"key20240412091849_b2-ol-27-5-14330","article-title":"Head and Neck Cancers","author":"National Cancer Institute"},{"key":"key20240412091849_b3-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jomfp.JOMFP_13_19","article-title":"Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders","volume":"23","author":"Ranganathan","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"key20240412091849_b4-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jop.12726","article-title":"Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis","volume":"47","author":"Mello","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"key20240412091849_b5-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cden.2013.12.004","article-title":"Oral Cancer: Leukoplakia, premalignancy, and squamous cell carcinoma","volume":"58","author":"Rhodus","year":"2014","journal-title":"Dent Clin North Am"},{"key":"key20240412091849_b6-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41598-019-57177-1","article-title":"Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"key20240412091849_b7-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/ijc.21237","article-title":"Different impact from betel quid, alcohol and cigarette: Risk factors for pharyngeal and laryngeal cancer","volume":"117","author":"Lee","year":"2005","journal-title":"Int J Cancer"},{"key":"key20240412091849_b8-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jjco\/hyu042","article-title":"Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma","volume":"44","author":"Saito","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"key20240412091849_b9-ol-27-5-14330","first-page":"2502","article-title":"Overexpression of HURP mRNA in head and neck carcinoma and association with in vitro response to vinorelbine","volume":"19","author":"Al-Khafaji","year":"2020","journal-title":"Oncol Lett"},{"key":"key20240412091849_b10-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3","article-title":"Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck","volume":"82","author":"Lewin","year":"1998","journal-title":"Cancer"},{"key":"key20240412091849_b11-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jop.12088","article-title":"Is there any benefit in surgery for potentially malignant disorders of the oral cavity?","volume":"43","author":"Balasundaram","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"key20240412091849_b12-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.oraloncology.2008.05.016","article-title":"Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management","volume":"45","author":"van der Waal","year":"2009","journal-title":"Oral Oncol"},{"key":"key20240412091849_b13-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.oraloncology.2015.06.015","article-title":"The management of oral epithelial dysplasia: The Liverpool algorithm","volume":"51","author":"Field","year":"2015","journal-title":"Oral Oncol"},{"key":"key20240412091849_b14-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"key20240412091849_b15-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.critrevonc.2017.01.020","article-title":"Epigenetic control of gene expression: Potential implications for cancer treatment","volume":"111","author":"Perri","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20240412091849_b16-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20240412091849_b17-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: Emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2021","journal-title":"Clin Epigenetics"},{"key":"key20240412091849_b18-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10822-020-00304-2","article-title":"Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach","volume":"34","author":"Sixto-L\u00f3pez","year":"2020","journal-title":"J Comput Aided Mol Des"},{"key":"key20240412091849_b19-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1369\/0022155413506582","article-title":"Histone Deacetylases: A saga of perturbed acetylation homeostasis in cancer","volume":"62","author":"Parbin","year":"2013","journal-title":"J Histochem Cytochem"},{"key":"key20240412091849_b20-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fncel.2015.00226","article-title":"Histone acetylation modifiers in the pathogenesis of Alzheimer's Disease","volume":"9","author":"Lu","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"key20240412091849_b21-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"641979","DOI":"10.1155\/2014\/641979","article-title":"Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases","volume":"2014","author":"Wang","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"key20240412091849_b22-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp Mol Med"},{"key":"key20240412091849_b23-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-019-1080-8","article-title":"Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis","volume":"38","author":"He","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"key20240412091849_b24-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/cancers12061664","article-title":"Roles of histone deacetylases and inhibitors in anticancer therapy","volume":"12","author":"Verza","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20240412091849_b25-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.552310","article-title":"Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression","volume":"24","author":"Yamaguchi","year":"2010","journal-title":"Genes Dev"},{"key":"key20240412091849_b26-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: Implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"key20240412091849_b27-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20240412091849_b28-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"169","DOI":"10.18632\/genesandcancer.54","article-title":"Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog","volume":"6","author":"Kumar","year":"2015","journal-title":"Genes Cancer"},{"key":"key20240412091849_b29-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20240412091849_b30-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hed.21734","article-title":"Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence","volume":"34","author":"Gan","year":"2012","journal-title":"Head Neck"},{"key":"key20240412091849_b31-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3325\/cmj.2017.58.349","article-title":"The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells","volume":"58","author":"Ma","year":"2017","journal-title":"Croat Med J"},{"key":"key20240412091849_b32-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-016-2957-y","article-title":"Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and\/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial","volume":"16","author":"Caponigro","year":"2016","journal-title":"BMC Cancer"},{"key":"key20240412091849_b33-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-tumor mechanisms of valproate: A novel role for an old drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med Res Rev"},{"key":"key20240412091849_b34-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"key20240412091849_b35-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"key20240412091849_b36-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20240412091849_b37-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/febs.15122","article-title":"Valproic acid targets HDAC1\/2 and HDAC1\/PTEN\/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer","volume":"287","author":"Sun","year":"2020","journal-title":"FEBS J"},{"key":"key20240412091849_b38-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/cncr.28479","article-title":"Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer","volume":"120","author":"Kang","year":"2014","journal-title":"Cancer"},{"key":"key20240412091849_b39-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3892\/or.2015.4145","article-title":"Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells","volume":"34","author":"Lee","year":"2015","journal-title":"Oncol Rep"},{"key":"key20240412091849_b40-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00280-008-0747-1","article-title":"Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas","volume":"63","author":"Erlich","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20240412091849_b41-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fcell.2020.00732","article-title":"Valproic acid synergizes with cisplatin and cetuximab in vitro and in vivo in head and neck cancer by targeting the mechanisms of resistance","volume":"8","author":"Iannelli","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"key20240412091849_b42-ol-27-5-14330","article-title":"SAVER: Sodium Valproate for the Epigenetic Reprogramming of High-Risk Oral Epithelial Dysplasia","author":"Liverpool Clinical Trials Centre (LCTC)","year":"2019"},{"key":"key20240412091849_b43-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.oraloncology.2008.08.011","article-title":"Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients","volume":"45","author":"Chang","year":"2009","journal-title":"Oral Oncol"},{"key":"key20240412091849_b44-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"8797206","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: Impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biomed Res Int"},{"key":"key20240412091849_b45-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1158\/1535-7163.MCT-07-0251","article-title":"Histone deacetylase inhibitors selectively suppress expression of HDAC7","volume":"6","author":"Dokmanovic","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20240412091849_b46-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13063-021-05373-8","article-title":"SAVER: Sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol","volume":"22","author":"McCarthy","year":"2021","journal-title":"Trials"},{"key":"key20240412091849_b47-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18632\/oncotarget.430","article-title":"A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer","volume":"3","author":"Stauber","year":"2012","journal-title":"Oncotarget"},{"key":"key20240412091849_b48-ol-27-5-14330","first-page":"1057","article-title":"Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: A special reference to gene-expression microarray analysis","volume":"26","author":"Iwahashi","year":"2011","journal-title":"Oncol Rep"},{"key":"key20240412091849_b49-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"12520","DOI":"10.1038\/s41598-018-31039-8","article-title":"HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"key20240412091849_b50-ol-27-5-14330","article-title":"HEAD AND NECK CANCER: 2014 Review of Cancer Medicines on the WHO List of Essential Medicines","author":"WHO","year":"2014"},{"key":"key20240412091849_b51-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bjoms.2013.03.014","article-title":"Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: Rationale for monitoring premalignant oral lesions in a multidisciplinary clinic","volume":"51","author":"Ho","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20240412091849_b52-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14639\/0392-100X-1246","article-title":"Prognostic factors in head and neck cancer: A 10-year retrospective analysis in a single-institution in Italy","volume":"37","author":"Cadoni","year":"2017","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"key20240412091849_b53-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.oooo.2013.09.017","article-title":"Malignant transformation of oral epithelial dysplasia: A real-world evaluation of histopathologic grading","volume":"117","author":"Dost","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"key20240412091849_b54-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20240412091849_b55-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mc.20373","article-title":"HDAC3 overexpression and colon cancer cell proliferation and differentiation","volume":"47","author":"Spurling","year":"2008","journal-title":"Mol Carcinog"},{"key":"key20240412091849_b56-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/ijc.25151","article-title":"Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin","volume":"127","author":"Hayashi","year":"2010","journal-title":"Int J Cancer"},{"key":"key20240412091849_b57-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3892\/etm.2016.3907","article-title":"Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro","volume":"12","author":"Sang","year":"2016","journal-title":"Exp Ther Med"},{"key":"key20240412091849_b58-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.bbagrm.2010.05.008","article-title":"Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions","volume":"1799","author":"Marks","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20240412091849_b59-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jop.12560","article-title":"Histone deacetylase 7 silencing induces apoptosis and autophagy in salivary mucoepidermoid carcinoma cells","volume":"46","author":"Ahn","year":"2017","journal-title":"J Oral Pathol Med"},{"key":"key20240412091849_b60-ol-27-5-14330","first-page":"125","article-title":"Anti-tumor effect of apicidin on Ishikawa human endometrial cancer cells both in vitro and in vivo by blocking histone deacetylase 3 and 4","volume":"36","author":"Ahn","year":"2010","journal-title":"Int J Oncol"},{"key":"key20240412091849_b61-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2012.06.017","article-title":"Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing","volume":"325","author":"Ahn","year":"2012","journal-title":"Cancer Lett"},{"key":"key20240412091849_b62-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/bjc.2016.36","article-title":"Inhibition of histone deacetylases in cancer therapy: Lessons from leukaemia","volume":"114","author":"Ceccacci","year":"2016","journal-title":"Br J Cancer"},{"key":"key20240412091849_b63-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4161\/cc.10.3.14712","article-title":"Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis","volume":"10","author":"Jurkin","year":"2011","journal-title":"Cell Cycle"},{"key":"key20240412091849_b64-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13148-018-0531-y","article-title":"Effects of novel HDAC inhibitors on urothelial carcinoma cells","volume":"10","author":"Kaletsch","year":"2018","journal-title":"Clin Epigenetics"},{"key":"key20240412091849_b65-ol-27-5-14330","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/diagnostics11030517","article-title":"Clinical significance of histone deacetylase (HDAC)-1, \u22122, \u22124 and \u22126 Expression in salivary gland tumors","volume":"11","author":"Pouloudi","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T02:18:56Z","timestamp":1712888336000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,7]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14330","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"article-number":"197"}}